Rebound Hound
Deep Dive: Rebound Stock Candidates – Scanner Hits 30/46 (Default Profile)
Analysis date: October 23, 2026 | Data snapshot from scanner run ~03:18
A default-profile rebound scanner recently flagged a set of names that matched a high percentage of its criteria (30 out of 46 hits). These stocks show relatively controlled drawdowns (mostly in the -3% to -10% range from recent highs), mid-range RSI readings (roughly 43–68), and moderate average true range (ATR) values. In plain terms, the list leans toward stocks that have pulled back modestly within broader uptrends rather than names that have collapsed.
Below is the raw scanner output for reference:
| Symbol | Score | Price | DD | RSI | ATR |
|---|---|---|---|---|---|
| CHEF | 161 | 107.29 | -10% | 43 | 3.9% |
| QLYS | 159 | 196.70 | -5% | 57 | 5.2% |
| CDNA | 155 | 70.74 | -3% | 68 | 6.4% |
| TRMD | 151 | 38.54 | -9% | 54 | 4.7% |
| TALO | 149 | 17.68 | -6% | 55 | 4.3% |
| KNSA | 145 | 79.70 | -5% | 54 | 3.8% |
| AMRX | 145 | 20.02 | -6% | 54 | 3.9% |
| GCT | 143 | 59.12 | -4% | 61 | 4.5% |
| EC | 140 | 17.24 | -6% | 50 | 2.8% |
| TRGP | 137 | 288.09 | -6% | 51 | 2.8% |
The list clusters around healthcare/pharma, energy, and selective technology/consumer names. Several companies are heading into earnings in the coming days or weeks, which adds event risk (and potential catalysts) to any technical setup.
Highest-Scoring Names
CHEF – The Chefs’ Warehouse (Score 161)
Food distribution focused on the independent restaurant and fine-dining channel. The stock has delivered strong year-to-date gains and has a history of earnings beats. The -10% drawdown is the deepest on the list and the RSI reading of 43 is the most constructive from a classic oversold-rebound standpoint. Longer-term moving averages remain well below the current price. Earnings are expected around October 28. Risks include valuation after a large run and any softening in restaurant demand.
QLYS – Qualys (Score 159)
Cybersecurity platform with multi-year revenue growth, high margins, and solid free-cash-flow characteristics. The pullback is modest (-5%) and RSI sits in neutral territory. Analyst views are mixed (more Hold than aggressive Buy), but the business quality and recent price action keep it on the radar for a controlled rebound or continuation if the broader tech complex holds up.
CDNA – CareDx (Score 155)
Precision medicine / transplant diagnostics name trading near recent highs with only a shallow -3% drawdown. RSI is elevated at 68, so this is closer to a continuation or consolidation setup than a deep rebound. Recent positive clinical data and upcoming earnings (around October 29) are near-term focal points. Higher ATR implies more volatility.
Energy & Shipping Names
TRMD – TORM (Score 151)
Product tanker operator benefiting from a firm rate environment. The stock carries a low trailing valuation multiple relative to many peers and has seen guidance raised. The -9% drawdown and mid-50s RSI give it a reasonable technical setup. Shipping remains cyclical; rate sustainability is the key variable.
TALO – Talos Energy & TRGP – Targa Resources
TALO (offshore E&P) and TRGP (midstream) both show modest drawdowns and neutral RSI readings. They carry oil and natural-gas volume exposure. TRGP has delivered strong multi-year performance and carries constructive longer-term analyst views, though the business model involves significant leverage. Both face earnings in early November.
EC – Ecopetrol
Colombian integrated energy company with the lowest ATR on the list. Valuation multiples are relatively low and the stock offers a dividend. Analyst consensus is mixed-to-cautious and country-specific / geopolitical risks apply. The technical setup is less pure “rebound momentum” than some of the higher-scoring names.
Healthcare & Specialty Pharma
KNSA – Kiniksa Pharmaceuticals (Score 145)
Specialty pharmaceutical company with strong commercial momentum in its lead product. The company has raised revenue guidance multiple times and the stock has posted large year-to-date gains. RSI is neutral after a modest pullback. Earnings are imminent. Single-product concentration and a rich valuation multiple are the primary risks.
AMRX – Amneal Pharmaceuticals (Score 145)
Generics, specialty, and biosimilars company that has posted solid year-to-date gains and recent earnings beats. New product launches provide potential catalysts. Analyst consensus is constructive. Earnings expected in early November.
Technology / E-commerce
GCT – GigaCloud Technology (Score 143)
B2B large-parcel e-commerce platform trading with a relatively modest valuation multiple and a modest -4% drawdown. RSI sits in the low 60s. The name has shown positive technical characteristics near recent highs. Earnings are due in early November.
Key Takeaways and Risks
- Most names on the list are experiencing shallow-to-moderate pullbacks inside longer-term uptrends rather than deep breakdowns.
- Lower-RSI names (particularly CHEF) offer more classic mean-reversion characteristics; higher-RSI names lean more toward continuation setups.
- Earnings season is the dominant near-term catalyst (and risk) for the majority of the list.
- Energy names add commodity beta; healthcare and select tech names add growth or defensive characteristics depending on the specific business.
- Broader market breadth, oil prices, and any earnings misses can quickly invalidate technical setups.
Scanner scores and technical readings are tools, not guarantees. Markets can remain irrational longer than expected, and individual company fundamentals can shift quickly.
Comments
Post a Comment